US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nasus Pharma Ltd.

7.33

+0.718110.86%

Post-market: 7.330.00000.00%16:04 EST

Volume:1.78K

Turnover:12.35K

Market Cap:66.42M

PE:-33.62

High:7.33

Open:6.75

Low:6.63

Close:6.61

52wk High:9.99

52wk Low:5.90

Shares:9.06M

Float Shares:3.98M

Volume Ratio:2.76

T/O Rate:0.04%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.2180

EPS(LYR):-0.2180

ROE:--

ROA:-116.06%

PB:-20.68

PE(LYR):-33.62

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Nasus Pharma Appoints Eyal Rubin as New CFO to Enhance Leadership

BRIEF-Nasus Pharma Strengthens Leadership Team, Appointing Eyal Rubin As Executive Vice President And Chief Financial Officer

Nasus Pharma Initiates Phase 2 Study of Needle-Free Epinephrine

BRIEF-Nasus Pharma Announces Initiation Of Phase 2 Clinical Study Of Ns002 With First Participant Dosed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/NSRX"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NSRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NSRX\",,,,,undefined,":{"symbol":"NSRX","market":"US","secType":"STK","nameCN":"Nasus Pharma Ltd.","latestPrice":7.3287,"timestamp":1764709200000,"preClose":6.6106,"halted":0,"volume":1775,"hourTrading":{"tag":"盘后","latestPrice":7.3287,"preClose":7.3287,"latestTime":"16:04 EST","volume":1,"amount":7.3287,"timestamp":1764709451353},"delay":0,"floatShares":3982680,"shares":9063458,"eps":-0.217993,"marketStatus":"Post-Mkt","change":0.7181,"latestTime":"12-02 16:40:42 EST","open":6.75,"high":7.3287,"low":6.63,"amount":12354.0984,"amplitude":0.105694,"askPrice":9.05,"askSize":100,"bidPrice":2.67,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-0.217993,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1764723600000},"marketStatusCode":4,"adr":0,"listingDate":1755057600000,"exchange":"NASDAQ","adjPreClose":6.6106,"postHourTrading":{"tag":"盘后","latestPrice":7.3287,"preClose":7.3287,"latestTime":"16:04 EST","volume":1,"amount":7.3287,"timestamp":1764709451353},"volumeRatio":2.757068},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NSRX\",,,,,undefined,":{"symbol":"NSRX","floatShares":3982680,"roa":"-116.06%","roe":"--","lyrEps":-0.217993,"volumeRatio":2.757068,"shares":9063458,"dividePrice":0,"high":7.3287,"amplitude":0.105694,"preClose":6.6106,"low":6.63,"week52Low":5.9,"pbRate":"-20.68","week52High":9.9899,"institutionHeld":0,"latestPrice":7.3287,"committee":0.333333,"eps":-0.217993,"divideRate":0,"volume":1775,"delay":0,"ttmEps":-0.217993,"open":6.75,"prevYearClose":8,"prevWeekClose":7,"prevMonthClose":7,"prevQuarterClose":6.65,"fiveDayClose":7.25,"twentyDayClose":7.61,"sixtyDayClose":8.01},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NSRX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NSRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NSRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1759294800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NSRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NSRX","date":"2025-12-01","current":-33.618969,"percent":0.88,"low":-51.389177,"twenty":-47.66361,"median":-46.687866,"eighty":-42.991866,"high":-35.481595,"avg":-45.597413,"sd":2.995208,"marketCap":63417438},"quantilePoints":[{"date":"2025-08-15","current":-47.343663,"twenty":-48.284655,"median":-47.931783,"eighty":-47.578911,"marketCap":72530491},{"date":"2025-08-22","current":-50.265593,"twenty":-50.691372,"median":-49.082873,"eighty":-48.024103,"marketCap":77006889},{"date":"2025-08-29","current":-47.604473,"twenty":-50.029049,"median":-48.047994,"eighty":-47.509856,"marketCap":72930053},{"date":"2025-09-05","current":-47.370886,"twenty":-49.082873,"median":-47.841017,"eighty":-47.486202,"marketCap":72572198},{"date":"2025-09-12","current":-48.136697,"twenty":-48.519903,"median":-47.66361,"eighty":-47.343663,"marketCap":73745420},{"date":"2025-09-19","current":-47.384488,"twenty":-48.195834,"median":-47.722745,"eighty":-47.36793,"marketCap":72593035},{"date":"2025-09-26","current":-47.604473,"twenty":-48.136697,"median":-47.604473,"eighty":-47.343663,"marketCap":72930053},{"date":"2025-10-03","current":-36.900859,"twenty":-48.077561,"median":-47.51577,"eighty":-47.308794,"marketCap":56532116},{"date":"2025-10-10","current":-45.830394,"twenty":-48.047993,"median":-47.384488,"eighty":-45.830394,"marketCap":70212163},{"date":"2025-10-17","current":-46.835706,"twenty":-47.900153,"median":-47.36793,"eighty":-45.534713,"marketCap":71752301},{"date":"2025-10-24","current":-44.943354,"twenty":-47.900153,"median":-47.314116,"eighty":-44.943354,"marketCap":68853218},{"date":"2025-10-31","current":-46.007802,"twenty":-47.900153,"median":-47.308794,"eighty":-45.239034,"marketCap":70483952},{"date":"2025-11-07","current":-44.647674,"twenty":-47.781881,"median":-47.308794,"eighty":-44.943354,"marketCap":68400236},{"date":"2025-11-14","current":-46.717433,"twenty":-47.722745,"median":-47.22009,"eighty":-44.647674,"marketCap":71571108},{"date":"2025-11-21","current":-41.395195,"twenty":-47.722745,"median":-46.835706,"eighty":-44.351994,"marketCap":63417438},{"date":"2025-11-28","current":-41.395195,"twenty":-47.675437,"median":-46.717433,"eighty":-43.654189,"marketCap":63417438},{"date":"2025-12-01","current":-41.395195,"twenty":-47.66361,"median":-46.687866,"eighty":-42.991866,"marketCap":63417438}],"updateTime":1764711642234},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NSRX\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2584373541","title":"Nasus Pharma Appoints Eyal Rubin as New CFO to Enhance Leadership","url":"https://stock-news.laohu8.com/highlight/detail?id=2584373541","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584373541?lang=en_us&edition=fundamental","pubTime":"2025-11-20 21:55","pubTimestamp":1763646914,"startTime":"0","endTime":"0","summary":"An announcement from Nasus Pharma Ltd. ( ($NSRX) ) is now available. Nasus Pharma Ltd. announced the appointment of Eyal Rubin as Executive Vice Pr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nasus-pharma-appoints-eyal-rubin-as-new-cfo-to-enhance-leadership?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nasus-pharma-appoints-eyal-rubin-as-new-cfo-to-enhance-leadership?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","NSRX"],"gpt_icon":0},{"id":"2584986134","title":"BRIEF-Nasus Pharma Strengthens Leadership Team, Appointing Eyal Rubin As Executive Vice President And Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2584986134","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584986134?lang=en_us&edition=fundamental","pubTime":"2025-11-20 21:15","pubTimestamp":1763644522,"startTime":"0","endTime":"0","summary":"BRIEF-Nasus Pharma Strengthens Leadership Team, Appointing Eyal Rubin As Executive Vice President And Chief Financial OfficerNasus Pharma Ltd NSRX.A:NASUS PHARMA STRENGTHENS LEADERSHIP TEAM, APPOINTIN","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nTUA8HFN8B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NSRX","BK4007"],"gpt_icon":0},{"id":"2584958035","title":"Nasus Pharma Initiates Phase 2 Study of Needle-Free Epinephrine","url":"https://stock-news.laohu8.com/highlight/detail?id=2584958035","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584958035?lang=en_us&edition=fundamental","pubTime":"2025-11-18 21:47","pubTimestamp":1763473675,"startTime":"0","endTime":"0","summary":"The latest update is out from Nasus Pharma Ltd. ( ($NSRX) ). On November 18, 2025, Nasus Pharma Ltd. announced the initiation of a Phase 2 clinical...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nasus-pharma-initiates-phase-2-study-of-needle-free-epinephrine?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nasus-pharma-initiates-phase-2-study-of-needle-free-epinephrine?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NSRX","BK4007"],"gpt_icon":0},{"id":"2584937088","title":"BRIEF-Nasus Pharma Announces Initiation Of Phase 2 Clinical Study Of Ns002 With First Participant Dosed","url":"https://stock-news.laohu8.com/highlight/detail?id=2584937088","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584937088?lang=en_us&edition=fundamental","pubTime":"2025-11-18 21:09","pubTimestamp":1763471364,"startTime":"0","endTime":"0","summary":"BRIEF-Nasus Pharma Announces Initiation Of Phase 2 Clinical Study Of Ns002 With First Participant DosedNasus Pharma Ltd NSRX.A:NASUS PHARMA ANNOUNCES INITIATION OF PHASE 2 CLINICAL STUDY OF NS002 WITH","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nTUACHCJVL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NSRX"],"gpt_icon":0}],"pageSize":4,"totalPage":6,"pageCount":1,"totalSize":23,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NSRX\",params:#limit:6,delay:false,,,undefined,":[]}}